December 23, 2013

Two experimental drugs under development by Biogen Idec are effective in reducing bleeding episodes in patients with two forms of hemophilia when administered as a preventive treatment, while also reducing the need for frequent injections, according to late-stage clinical trial data.

November 28, 2012

Novo Nordisk has launched a mobile app for hemophilia patients, the drug maker said.

November 22, 2010

Specialty pharmacy provider Axium Healthcare Pharmacy has received recognition from the National Hemophilia Foundation for its treatment programs ...

October 31, 2010

The U.S. subsidiary of a Swiss biotech company has started a late-stage trial of a...